Inovio Pharmaceuticals Inc vs 3M Company — how do they compare? Inovio Pharmaceuticals Inc trades at $0.77 (market cap $78.55M), while 3M Company trades at $182.16 (market cap $94.44B). The key difference: 3M Company is far larger — about 1202.3× Inovio Pharmaceuticals Inc's market cap, and 3M Company pays a 1.7% dividend while Inovio Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| INO | MMM | |
|---|---|---|
Market Cap | $78.55M | $94.44B |
Sector | Health | Industrials |
52-Week High | $2.87 | $183.13 |
52-Week Low | $0.66 | $141.10 |
Enterprise Value | $49.56M | $103.67B |
Dividend Yield | — | 1.7% |
Trailing returns across standard periods
Latest headlines on both assets
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Read more on INO →3M Company conducts operations in electronics, telecommunications, industrial, consumer and office, health care, safety, and other markets. The Company businesses share technologies, manufacturing operations, marketing channels, and other resources. 3M serves customers worldwide.
Read more on MMM →